Sept 26 (Reuters) - EMA:
* EMA: EMA'S CHMP STARTED EVALUATING AN APPLICATION FOR THE AUTHORISATION OF AN ADDITIONAL ADAPTED VERSION OF SPIKEVAX: 26/09/2022 Further company coverage:
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
123.9 USD | +5.66% | +0.40% | +23.30% |
09:45am | Moderna Insider Sold Shares Worth $1,825,220, According to a Recent SEC Filing | MT |
May. 10 | Equities Mostly Rise as Traders Parse Fed Officials' Comments, Consumer Sentiment Survey | MT |
Sept 26 (Reuters) - EMA:
* EMA: EMA'S CHMP STARTED EVALUATING AN APPLICATION FOR THE AUTHORISATION OF AN ADDITIONAL ADAPTED VERSION OF SPIKEVAX: 26/09/2022 Further company coverage:
1st Jan change | Capi. | |
---|---|---|
+23.30% | 44.96B | |
+1.03% | 42.65B | |
+46.11% | 41.85B | |
-4.27% | 29.04B | |
+10.74% | 26.08B | |
-20.62% | 19.03B | |
+5.72% | 12.75B | |
+28.14% | 12.06B | |
-4.03% | 11.75B | |
+21.47% | 11.72B |